udt-logo-verdana-white-3
  • About us
  • Investment focus
  • Team
  • Investment proposal
  • contact
  • en
  • nl
AdobeStock_98985434
  1. Home›
  2. News

News.

Read the latest news here.

Category
  • News
  • Press
  • Case
  • Event
  • Article
  • Blog
  • Story
Market
  • Aerospace
  • Agri & Food
  • Defense & Security
  • Energy
  • High-tech systems & Materials
  • Life sciences & Health
  • Smart industries
  • Water & Maritime
Latest
  • Latest
  • Oldest
curix-unlooc-advancements-neurological-drug-delivery-3curix-unlooc-advancements-neurological-drug-delivery-3
News

Curix advances neurological drug delivery in European UNLOOC project.

As part of the ambitious European research initiative UNLOOC (Unlocking the data content of Organ-on-Chips), Curix is pioneering new methods for drug delivery to the brain, aiming to transform treatment approaches for neurological diseases such as Alzheimer’s and brain tumors.

Read more
DEMCON unmanned systems joins Dutch Naval Design consortium for next-gen 12m naval USVs!DEMCON unmanned systems joins Dutch Naval Design consortium for next-gen 12m naval USVs!
News

Demcon unmanned systems joins Dutch Naval Design consortium for next-gen 12m naval USVs!

Read more
DEMCON_KS_9NOV20_2211_HRDEMCON_KS_9NOV20_2211_HR
News

Anniversary: 10 years part of the Demcon group.

Celebrating 10 years of Demcon Multiphysics! Discover our journey of innovation, growth, and engineering excellence as part of the Demcon Group.

Read more
Sync biosystems illustration bannerSync biosystems illustration banner
Press

Sync Biosystems secures €2.5M to validate technology with international end users

Precise fluidic control to improve cell culture and drug testing The international δypha Consortium has received a European Innovation Council Transition grant of 2.5 million euros for bringing Sync Biosystems’ technology from pilot to product. Industrial and research leaders, integral members of the consortium, participate as end users: Charles River Laboratories, Princess Máxima Center for Pediatric Oncology and Bambino Gesù Children’s Hospital. With dedicated showcases, they will demonstrate how the technology impacts their drug development assays and their search for better therapies for patients. To translate the results from the in vitro technology to patient-relevant levels, consortium partner ESQlabs will develop specific physiologically-based computational models. The goal of δypha is to improve cell culture and drug testing with automated and continuous fluidic control in standard cell culture plates.

Read more
demcon-groningen-news-innovatrion clusterdemcon-groningen-news-innovatrion cluster
Press

Demcon Groningen strengthens Innovatie Cluster Drachten. A strategic partnership for the future

Read more
TNO and DemconTNO and Demcon
Press

TNO and Demcon provide the world’s largest telescope with sharp vision

Delivery of first Laser Projection System to European Southern Observatory Technology developer and producer Demcon shipped the first Laser Projection System together with TNO last week. Its destination is the European Southern Observatory (ESO), where TNO and ESO will test the system. In total, Demcon company Focal and TNO will build nine systems for ESO’s Very Large Telescope and Extremely Large Telescope in Chile. The systems project ‘laser guide stars’ into the atmosphere to help the large telescopes better focus on distant astronomical objects. This gives astronomers sharper images of the universe. They hope to make new discoveries, for example about the evolution of the universe after the Big Bang and the formation of stars and galaxies.

Read more
« ‹
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263
› »
Page 34 of 63
udt-logo-verdana-white-3
About usInvestment focusTeamInvestment proposal

Contact us

send a message
cookie policyprivacy statement
© 2026 UDT. All rights reserved.